BPC-157 is typically administered in research protocols via subcutaneous injection after sterile reconstitution with bacteriostatic water, with oral routes also discussed (see oral peptide delivery)
Running them together doubles GI side effects without additional fat loss benefit
Remove the needle, apply light pressure with gauze, and dispose of the syringe in a sharps container
Oral BPC-157 for Gastrointestinal Conditions Injectable BPC-157 for Musculoskeletal Conditions Injection Technique and Patient Education All patients receiving injectable BPC-157 are provided with: Detailed written instructions for reconstitution, storage, and administration In-person or video training on proper subcutaneous injection technique Sharps disposal containers and guidance on safe disposal 24-hour clinical contact for questions or concerns Most patients self-administer injections after the first week of supervised dosing
Modulation of early functional recovery of Achilles tendon to bone unit after transection by BPC 157 and methylprednisolone
Insulin, the very first lab-made peptide, signaled the launch of modern peptide therapeutics in 1921